- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Altana’s Protium materials compared to Nexium used “equivalent/comparable” healing and symptom claims and “2 days faster” messaging. PMCPA…
PMCPA case AUTH/2999/12/17 (Director v Otsuka) about clinical trial disclosure for Deltyba. Outcome: no breach; matter found outwith…
PMCPA case summary: Head of Medicines Optimisation complaint against GlaxoSmithKline. The provided case text contains no details of…
Complaint alleged advertising of an unlicensed medicine. PMCPA recorded no breach because the matter was outwith the scope…
PMCPA found Ilumetri website headline claims on dosing, efficacy and QoL misleading/unsupported (Clauses 7.2, 7.4) and ruled high…
A Cortiment rotating banner used the strapline “For flaring mild to moderate UC patients”, which the Panel said…
Sanofi’s Toujeo DoubleStar slide deck wrongly claimed “fewer prescriptions”. PMCPA ruled the claim misleading and unsubstantiated, and found…
Anonymous employee alleged Toujeo/Suliqua “advocate” programme induced prescribing and misused HCP data. Panel found no inducement/GDPR breach, but…
PMCPA found Novartis breached the ABPI Code over an Entresto nurse podcast: an unsubstantiated ‘energy’ claim, ‘best’ implying…
GSK’s HCP webpage/video used an NMA to headline “greater exacerbation reduction” vs other COPD SITTs. PMCPA ruled the…
One real case. One key lesson. Every week — free.